Showing 181 - 200 results of 1,181 for search '"EMBO Molecular Medicine"', query time: 0.08s Refine Results
  1. 181
    Elucidating effects of environmental exposure using human‐induced pluripotent stem cell disease modeling

    Elucidating effects of environmental exposure using human‐induced pluripotent stem cell disease modeling by Mark Chandy, Detlef Obal, Joseph C Wu

    Published 2022-10-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 182
    Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity

    Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity by Yi-Cheng Chang, Meng-Lun Hsieh, Hsiao-Lin Lee, Siow-Wey Hee, Chi-Fon Chang, Hsin-Yung Yen, Yi-An Chen, Yet-Ran Chen, Ya-Wen Chou, Fu-An Li, Yi-Yu Ke, Shih-Yi Chen, Ming-Shiu Hung, Alfur Fu-Hsin Hung, Jing-Yong Huang, Chu-Hsuan Chiu, Shih-Yao Lin, Sheue-Fang Shih, Chih-Neng Hsu, Juey-Jen Hwang, Teng-Kuang Yeh, Ting-Jen Rachel Cheng, Karen Chia-Wen Liao, Daniel Laio, Shu-Wha Lin, Tzu-Yu Chen, Chun-Mei Hu, Ulla Vogel, Daniel Saar, Birthe B Kragelund, Lun Kelvin Tsou, Yu-Hua Tseng, Lee-Ming Chuang

    Published 2025-04-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 183
    D‐Aspartate treatment attenuates myelin damage and stimulates myelin repair

    D‐Aspartate treatment attenuates myelin damage and stimulates myelin repair by Valeria de Rosa, Agnese Secondo, Anna Pannaccione, Roselia Ciccone, Luigi Formisano, Natascia Guida, Roberta Crispino, Annalisa Fico, Roman Polishchuk, Antimo D'Aniello, Lucio Annunziato, Francesca Boscia

    Published 2018-12-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 184
    Tumor cell‐specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase

    Tumor cell‐specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase by Stefanie Peter, Jennyfer Bultinck, Kevin Myant, Laura A Jaenicke, Susanne Walz, Judith Müller, Michael Gmachl, Matthias Treu, Guido Boehmelt, Carsten P Ade, Werner Schmitz, Armin Wiegering, Christoph Otto, Nikita Popov, Owen Sansom, Norbert Kraut, Martin Eilers

    Published 2014-09-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 185
    USP14 inhibition corrects an in vivo model of impaired mitophagy

    USP14 inhibition corrects an in vivo model of impaired mitophagy by Joy Chakraborty, Sophia von Stockum, Elena Marchesan, Federico Caicci, Vanni Ferrari, Aleksandar Rakovic, Christine Klein, Angelo Antonini, Luigi Bubacco, Elena Ziviani

    Published 2018-09-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 186
    An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors

    An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors by Maicol Mancini, Hilah Gal, Nadège Gaborit, Luigi Mazzeo, Donatella Romaniello, Tomer Meir Salame, Moshit Lindzen, Georg Mahlknecht, Yehoshua Enuka, Dominick GA Burton, Lee Roth, Ashish Noronha, Ilaria Marrocco, Dan Adreka, Raya Eilam Altstadter, Emilie Bousquet, Julian Downward, Antonio Maraver, Valery Krizhanovsky, Yosef Yarden

    Published 2017-12-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 187
    A new twist to the emerging functions of ceramides in cancer: novel role for platelet acid sphingomyelinase in cancer metastasis

    A new twist to the emerging functions of ceramides in cancer: novel role for platelet acid sphingomyelinase in cancer metastasis by Yusuf A Hannun, Benjamin Newcomb

    Published 2015-04-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 188
    The ups and downs of caloric restriction and fasting: from molecular effects to clinical application

    The ups and downs of caloric restriction and fasting: from molecular effects to clinical application by Sebastian J Hofer, Didac Carmona‐Gutierrez, Melanie I Mueller, Frank Madeo

    Published 2021-11-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 189
    A novel epigenetic AML1‐ETO/THAP10/miR‐383 mini‐circuitry contributes to t(8;21) leukaemogenesis

    A novel epigenetic AML1‐ETO/THAP10/miR‐383 mini‐circuitry contributes to t(8;21) leukaemogenesis by Yonghui Li, Qiaoyang Ning, Jinlong Shi, Yang Chen, Mengmeng Jiang, Li Gao, Wenrong Huang, Yu Jing, Sai Huang, Anqi Liu, Zhirui Hu, Daihong Liu, Lili Wang, Clara Nervi, Yun Dai, Michael Q Zhang, Li Yu

    Published 2017-05-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 190
    Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis

    Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis by Jinbeom Heo, Byeong‐Joo Noh, Seungun Lee, Hye‐Yeon Lee, YongHwan Kim, Jisun Lim, Hyein Ju, Hwan Yeul Yu, Chae‐Min Ryu, Peter CW Lee, Hwangkyo Jeong, Yumi Oh, Kyunggon Kim, Sang‐Yeob Kim, Jaekyoung Son, Bumsik Hong, Jong Soo Kim, Yong Mee Cho, Dong‐Myung Shin

    Published 2019-11-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 191
    IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment

    IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment by Sophia Davidson, Teresa M McCabe, Stefania Crotta, Hans Henrik Gad, Edith M Hessel, Soren Beinke, Rune Hartmann, Andreas Wack

    Published 2016-08-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 192
    PATL2 is a key actor of oocyte maturation whose invalidation causes infertility in women and mice

    PATL2 is a key actor of oocyte maturation whose invalidation causes infertility in women and mice by Marie Christou‐Kent, Zine‐Eddine Kherraf, Amir Amiri‐Yekta, Emilie Le Blévec, Thomas Karaouzène, Béatrice Conne, Jessica Escoffier, Said Assou, Audrey Guttin, Emeline Lambert, Guillaume Martinez, Magalie Boguenet, Selima Fourati Ben Mustapha, Isabelle Cedrin Durnerin, Lazhar Halouani, Ouafi Marrakchi, Mounir Makni, Habib Latrous, Mahmoud Kharouf, Charles Coutton, Nicolas Thierry‐Mieg, Serge Nef, Serge P Bottari, Raoudha Zouari, Jean Paul Issartel, Pierre F Ray, Christophe Arnoult

    Published 2018-04-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 193
    PARP7 as a new target for activating anti-tumor immunity in cancer

    PARP7 as a new target for activating anti-tumor immunity in cancer by Katerina Popova, Johannes Benedum, Magdalena Engl, Carola Lütgendorf-Caucig, Piero Fossati, Joachim Widder, Klaus Podar, Dea Slade

    Published 2025-03-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 194
    Enhancement of efferocytosis through biased FPR2 signaling attenuates intestinal inflammation

    Enhancement of efferocytosis through biased FPR2 signaling attenuates intestinal inflammation by Ming‐Yue Wu, Yun‐Jun Ge, Er‐Jin Wang, Qi‐Wen Liao, Zheng‐Yu Ren, Yang Yu, Guoyuan Zhu, Chun‐Ping Liu, Meng‐Ni Zhang, Huanxing Su, Han‐Ming Shen, Ye Chen, Lei Wang, Yi‐Tao Wang, Min Li, Zhaoxiang Bian, Jin Chai, Richard D Ye, Jia‐Hong Lu

    Published 2023-11-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 195
    Modulation of mTOR signaling as a strategy for the treatment of Pompe disease

    Modulation of mTOR signaling as a strategy for the treatment of Pompe disease by Jeong‐A Lim, Lishu Li, Orian S Shirihai, Kyle M Trudeau, Rosa Puertollano, Nina Raben

    Published 2017-01-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 196
    Cross‐presentation of malaria antigen by brain microvessels: why CD8+ T cells are critical for the pathogenesis of experimental cerebral malaria

    Cross‐presentation of malaria antigen by brain microvessels: why CD8+ T cells are critical for the pathogenesis of experimental cerebral malaria by Katsuyuki Yui

    Published 2013-06-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 197
    Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ‐secretase inhibitor drug responses

    Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ‐secretase inhibitor drug responses by Diana J. Azzam, Dekuang Zhao, Jun Sun, Andy J. Minn, Prathibha Ranganathan, Katherine Drews‐Elger, Xiaoqing Han, Manuel Picon‐Ruiz, Candace A. Gilbert, Seth A. Wander, Anthony J. Capobianco, Dorraya El‐Ashry, Joyce M. Slingerland

    Published 2013-08-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 198
    Inhibition of Aurora Kinase B attenuates fibroblast activation and pulmonary fibrosis

    Inhibition of Aurora Kinase B attenuates fibroblast activation and pulmonary fibrosis by Rajesh K Kasam, Sudhir Ghandikota, Divyalakshmi Soundararajan, Geereddy B Reddy, Steven K Huang, Anil G Jegga, Satish K Madala

    Published 2020-08-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 199
    Metabolic and hypoxic adaptation to anti‐angiogenic therapy: a target for induced essentiality

    Metabolic and hypoxic adaptation to anti‐angiogenic therapy: a target for induced essentiality by Alan McIntyre, Adrian L Harris

    Published 2015-02-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 200
    Metabolic effects of bezafibrate in mitochondrial disease

    Metabolic effects of bezafibrate in mitochondrial disease by Hannah Steele, Aurora Gomez‐Duran, Angela Pyle, Sila Hopton, Jane Newman, Renae J Stefanetti, Sarah J Charman, Jehill D Parikh, Langping He, Carlo Viscomi, Djordje G Jakovljevic, Kieren G Hollingsworth, Alan J Robinson, Robert W Taylor, Leonardo Bottolo, Rita Horvath, Patrick F Chinnery

    Published 2020-02-01
    “…EMBO Molecular Medicine…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: